Valion Bio (VBIO)
Develops radiation-injury immunotherapeutics and offers biologics CDMO services.
$3.04
Pre-market−0.13 (−4.04%)
At close$3.17(+3.19%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
4.91M company shares as of Sep 3, 2026 · holders as of their latest filing
Two share counts disagree (4.91M in the company's Sep 3, 2026 report, 4.14M elsewhere); stakes use the report.
Institutions13F
No 13F holders on record.
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| 3i, LP | 9.90% | 13G | May 8, 2026 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.